Antimicrobial activity of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia

Abstract Stenotrophomonas maltophilia is increasingly recognised as an important nosocomial pathogen. Treatment options are limited due to intrinsic resistance to many antibiotics as well as concerns over toxicity of the mainstay of treatment, co-trimoxazole. Epigallocatechin-3-gallate (EGCG), the m...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of antimicrobial agents Vol. 36; no. 2; pp. 129 - 131
Main Authors Gordon, Nicola C, Wareham, David W
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.08.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Stenotrophomonas maltophilia is increasingly recognised as an important nosocomial pathogen. Treatment options are limited due to intrinsic resistance to many antibiotics as well as concerns over toxicity of the mainstay of treatment, co-trimoxazole. Epigallocatechin-3-gallate (EGCG), the major catechin found in green tea, has been shown to have antimicrobial effects against a number of bacterial pathogens. We evaluated the in vitro activity of this compound against 40 clinical isolates of S. maltophilia . MIC50/90 values (minimal inhibitory concentrations for 50% and 90% of the organisms, respectively) were 256 mg/L when determined by agar dilution and 512 mg/L by broth microdilution. MBC50/90 values (minimal bactericidal concentrations for 50% and 90% of the organisms, respectively) were 512 mg/L. In time–kill assays, the bactericidal activity of EGCG was analysed by viable colony counts as well as a colorimetric assay for bacterial reduction of XTT. EGCG was slowly bactericidal at 4× MIC, with a 2.5 log reduction in viable bacteria at 24 h. EGCG has promising in vitro antimicrobial activity against S. maltophilia . Although the mechanism of action is not yet clear, further studies to evaluate its clinical potential and role in combination with other antimicrobial agents are warranted.
AbstractList Stenotrophomonas maltophilia is increasingly recognised as an important nosocomial pathogen. Treatment options are limited due to intrinsic resistance to many antibiotics as well as concerns over toxicity of the mainstay of treatment, co-trimoxazole. Epigallocatechin-3-gallate (EGCG), the major catechin found in green tea, has been shown to have antimicrobial effects against a number of bacterial pathogens. We evaluated the in vitro activity of this compound against 40 clinical isolates of S. maltophilia. MIC sub(50/90) values (minimal inhibitory concentrations for 50% and 90% of the organisms, respectively) were 256 mg/L when determined by agar dilution and 512 mg/L by broth microdilution. MBC sub(50/90) values (minimal bactericidal concentrations for 50% and 90% of the organisms, respectively) were 512 mg/L. In time-kill assays, the bactericidal activity of EGCG was analysed by viable colony counts as well as a colorimetric assay for bacterial reduction of XTT. EGCG was slowly bactericidal at 4x MIC, with a 2.5 log reduction in viable bacteria at 24 h. EGCG has promising in vitro antimicrobial activity against S. maltophilia. Although the mechanism of action is not yet clear, further studies to evaluate its clinical potential and role in combination with other antimicrobial agents are warranted.
Abstract Stenotrophomonas maltophilia is increasingly recognised as an important nosocomial pathogen. Treatment options are limited due to intrinsic resistance to many antibiotics as well as concerns over toxicity of the mainstay of treatment, co-trimoxazole. Epigallocatechin-3-gallate (EGCG), the major catechin found in green tea, has been shown to have antimicrobial effects against a number of bacterial pathogens. We evaluated the in vitro activity of this compound against 40 clinical isolates of S. maltophilia . MIC50/90 values (minimal inhibitory concentrations for 50% and 90% of the organisms, respectively) were 256 mg/L when determined by agar dilution and 512 mg/L by broth microdilution. MBC50/90 values (minimal bactericidal concentrations for 50% and 90% of the organisms, respectively) were 512 mg/L. In time–kill assays, the bactericidal activity of EGCG was analysed by viable colony counts as well as a colorimetric assay for bacterial reduction of XTT. EGCG was slowly bactericidal at 4× MIC, with a 2.5 log reduction in viable bacteria at 24 h. EGCG has promising in vitro antimicrobial activity against S. maltophilia . Although the mechanism of action is not yet clear, further studies to evaluate its clinical potential and role in combination with other antimicrobial agents are warranted.
Stenotrophomonas maltophilia is increasingly recognised as an important nosocomial pathogen. Treatment options are limited due to intrinsic resistance to many antibiotics as well as concerns over toxicity of the mainstay of treatment, co-trimoxazole. Epigallocatechin-3-gallate (EGCG), the major catechin found in green tea, has been shown to have antimicrobial effects against a number of bacterial pathogens. We evaluated the in vitro activity of this compound against 40 clinical isolates of S. maltophilia. MIC 50/90 values (minimal inhibitory concentrations for 50% and 90% of the organisms, respectively) were 256 mg/L when determined by agar dilution and 512 mg/L by broth microdilution. MBC 50/90 values (minimal bactericidal concentrations for 50% and 90% of the organisms, respectively) were 512 mg/L. In time–kill assays, the bactericidal activity of EGCG was analysed by viable colony counts as well as a colorimetric assay for bacterial reduction of XTT. EGCG was slowly bactericidal at 4× MIC, with a 2.5 log reduction in viable bacteria at 24 h. EGCG has promising in vitro antimicrobial activity against S. maltophilia. Although the mechanism of action is not yet clear, further studies to evaluate its clinical potential and role in combination with other antimicrobial agents are warranted.
Stenotrophomonas maltophilia is increasingly recognised as an important nosocomial pathogen. Treatment options are limited due to intrinsic resistance to many antibiotics as well as concerns over toxicity of the mainstay of treatment, co-trimoxazole. Epigallocatechin-3-gallate (EGCG), the major catechin found in green tea, has been shown to have antimicrobial effects against a number of bacterial pathogens. We evaluated the in vitro activity of this compound against 40 clinical isolates of S. maltophilia. MIC(50/90) values (minimal inhibitory concentrations for 50% and 90% of the organisms, respectively) were 256 mg/L when determined by agar dilution and 512 mg/L by broth microdilution. MBC(50/90) values (minimal bactericidal concentrations for 50% and 90% of the organisms, respectively) were 512 mg/L. In time-kill assays, the bactericidal activity of EGCG was analysed by viable colony counts as well as a colorimetric assay for bacterial reduction of XTT. EGCG was slowly bactericidal at 4x MIC, with a 2.5 log reduction in viable bacteria at 24h. EGCG has promising in vitro antimicrobial activity against S. maltophilia. Although the mechanism of action is not yet clear, further studies to evaluate its clinical potential and role in combination with other antimicrobial agents are warranted.
Author Wareham, David W
Gordon, Nicola C
Author_xml – sequence: 1
  fullname: Gordon, Nicola C
– sequence: 2
  fullname: Wareham, David W
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22980179$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20472404$$D View this record in MEDLINE/PubMed
BookMark eNqNUstuEzEUHaEimhZ-AZkFol1M8DMzs6lURSUgVWJRWFt3PHbiMGMPtlMpf8Aa8YX9knqUFBArVta1zz33-Jx7Vpw473RRvCF4TjBZvN_O7RZcsoNVsJ5TnO8xm2MqnhUzUle0rBrCTooZbigva1E1p8VZjFuMiWBcvChOKeYV5ZjPil_XB57gWws9ApXsvU175A1KG43WQWuHkgY0-n4_brTzPbp4-PHzstSjXUPfewVJq411JSunOlfo4ma1XF0iWIN1MSHVW5eV9shGP73Hif0uZa4U_Ljxg3cQ0QB9ypXtLbwsnhvoo351PM-Lrx9uviw_lrefV5-W17elEqJJZVsbEBhXnFJeC2UabgjUmHfYcGgodB0TnIpFtTCEMaxoW6vWmJosoDXQEXZevDvwjsF_3-mY5GCj0vkTTvtdlJXggtWCNBnZHJDZqBiDNnIMdoCwlwTLKRO5lX9lIqdMJGYyZ5J7Xx-n7NpBd787n0LIgLdHAMRskwnglI1_cLSpMakmEcsDTmdP7q0OMiqrndKdDVol2Xn7X3Ku_mF5yueb3uu49bvgsumSyEgllnfTEk07RPC0P03FHgGOmMpC
CitedBy_id crossref_primary_10_1016_j_vetmic_2012_12_039
crossref_primary_10_1002_fsn3_1535
crossref_primary_10_1007_s11064_015_1584_3
crossref_primary_10_1016_j_carbpol_2016_06_026
crossref_primary_10_1016_j_chemosphere_2019_05_205
crossref_primary_10_1111_ger_12132
crossref_primary_10_3390_dj6030038
crossref_primary_10_13055_ojgen_3_1_1_140317
crossref_primary_10_1002_app_51261
crossref_primary_10_1007_s11274_012_1149_4
crossref_primary_10_1002_elsc_201400143
crossref_primary_10_1016_j_archoralbio_2020_104727
crossref_primary_10_2478_alife_2018_0023
crossref_primary_10_1039_D0RA05548D
crossref_primary_10_1080_10826068_2015_1135457
crossref_primary_10_15446_rcciquifa_v45n1_58023
crossref_primary_10_2527_jas2017_1859
crossref_primary_10_1186_s12906_017_1597_3
crossref_primary_10_1371_journal_pone_0118431
crossref_primary_10_2174_1872208316666220512121205
crossref_primary_10_3389_fmicb_2014_00434
crossref_primary_10_7717_peerj_3467
crossref_primary_10_1128_spectrum_02582_21
crossref_primary_10_1099_jmm_0_032201_0
crossref_primary_10_1016_j_colsurfb_2014_09_042
crossref_primary_10_3390_molecules26206123
crossref_primary_10_1155_2014_248656
crossref_primary_10_1016_j_lwt_2021_112885
crossref_primary_10_3389_fmicb_2017_02276
crossref_primary_10_1016_j_bbrep_2015_10_013
crossref_primary_10_1016_j_livsci_2013_11_026
crossref_primary_10_1093_fqsafe_fyad039
crossref_primary_10_1021_acssuschemeng_8b01613
crossref_primary_10_1111_ppa_12364
crossref_primary_10_3390_coatings10060537
crossref_primary_10_1371_journal_pone_0092876
crossref_primary_10_3389_fmicb_2019_02362
crossref_primary_10_1186_1471_2180_14_172
crossref_primary_10_1111_ijfs_15268
crossref_primary_10_3389_fnut_2021_812741
crossref_primary_10_1007_s11095_013_1266_2
crossref_primary_10_1007_s00044_011_9800_4
crossref_primary_10_1038_srep21140
crossref_primary_10_1016_j_ijbiomac_2023_128203
crossref_primary_10_1515_msac_2015_0014
crossref_primary_10_1186_1472_6882_11_115
crossref_primary_10_3390_nu6126020
crossref_primary_10_3389_fmicb_2019_02646
crossref_primary_10_1016_j_ijantimicag_2011_07_006
crossref_primary_10_1016_j_carbpol_2016_08_056
crossref_primary_10_1111_j_1439_0531_2012_01984_x
crossref_primary_10_1016_j_ijpharm_2014_08_053
crossref_primary_10_1007_s00044_012_0352_z
crossref_primary_10_1016_j_biopha_2017_09_024
crossref_primary_10_1021_acsomega_7b01902
crossref_primary_10_1016_j_foodcont_2012_10_021
crossref_primary_10_1099_jmm_0_001060
crossref_primary_10_1016_j_jep_2010_10_021
crossref_primary_10_1128_AAC_00651_13
crossref_primary_10_1155_2017_5813793
crossref_primary_10_1177_8756087916631602
crossref_primary_10_1016_j_joen_2016_10_017
crossref_primary_10_1016_j_jtice_2020_08_015
crossref_primary_10_1155_2014_863984
crossref_primary_10_1016_j_compositesb_2022_109920
crossref_primary_10_1002_btpr_3319
crossref_primary_10_3390_antiox11030459
crossref_primary_10_1016_j_fbio_2021_101320
crossref_primary_10_1136_jcp_2010_083469
crossref_primary_10_1039_D2MA00642A
crossref_primary_10_1016_j_foodres_2014_01_036
crossref_primary_10_26599_FSHW_2022_9250063
crossref_primary_10_1016_j_foodres_2023_112703
crossref_primary_10_3390_pr8121566
crossref_primary_10_1111_lam_13712
crossref_primary_10_3389_fmicb_2022_1029098
crossref_primary_10_1016_j_heliyon_2024_e26940
crossref_primary_10_1128_CMR_00019_11
crossref_primary_10_1007_s00284_022_02978_3
crossref_primary_10_1080_03235408_2017_1329131
crossref_primary_10_1007_s12026_015_8681_x
crossref_primary_10_2174_0929867324666170920161246
crossref_primary_10_1007_s12223_012_0198_2
crossref_primary_10_1002_ptr_6697
crossref_primary_10_1016_j_micres_2023_127548
crossref_primary_10_1039_C7CP02771K
crossref_primary_10_1111_1541_4337_12346
crossref_primary_10_1016_j_ijantimicag_2011_02_014
crossref_primary_10_1111_bph_12009
crossref_primary_10_1016_j_ijbiomac_2021_11_146
crossref_primary_10_1016_j_fitote_2016_07_009
crossref_primary_10_1016_j_sajb_2016_08_020
crossref_primary_10_1016_j_phymed_2018_09_169
crossref_primary_10_3390_antibiotics11010046
Cites_doi 10.1007/s10156-003-0284-0
10.1007/s10096-007-0279-3
10.1186/gb-2008-9-4-r74
10.1271/bbb.60.2066
10.1111/j.1524-475X.2008.00422.x
10.1016/j.bbrc.2006.06.037
10.1016/j.jhep.2006.05.005
10.1053/jhin.2001.1099
10.1128/CMR.11.1.57
10.1017/S0950268898008735
10.1093/jac/dkp094
10.1001/jama.296.10.1255
10.1093/jac/dkp244
10.1016/S0196-6553(99)70077-5
10.1021/jm060817o
10.1111/j.1600-0625.2008.00818.x
10.1211/002235703765951320
10.1016/j.biocel.2005.10.021
10.1128/AAC.49.7.2914-2920.2005
10.3201/eid1304.061378
10.1016/j.mimet.2004.11.010
10.1016/0005-2736(93)90323-R
10.1111/j.1469-0691.2009.02710.x
ContentType Journal Article
Copyright Elsevier B.V. and the International Society of Chemotherapy
2010 Elsevier B.V. and the International Society of Chemotherapy
2015 INIST-CNRS
Copyright (c) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Copyright_xml – notice: Elsevier B.V. and the International Society of Chemotherapy
– notice: 2010 Elsevier B.V. and the International Society of Chemotherapy
– notice: 2015 INIST-CNRS
– notice: Copyright (c) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T7
8FD
C1K
FR3
P64
DOI 10.1016/j.ijantimicag.2010.03.025
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Engineering Research Database
Technology Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Bacteriology Abstracts (Microbiology B)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList Engineering Research Database


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1872-7913
EndPage 131
ExternalDocumentID 10_1016_j_ijantimicag_2010_03_025
20472404
22980179
S0924857910001597
1_s2_0_S0924857910001597
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29J
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADVLN
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CJTIS
CNWQP
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMG
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
LUGTX
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OD-
OO.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SIN
SPCBC
SSH
SSI
SSZ
T5K
UNMZH
WUQ
XPP
Z5R
~G-
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
ABPIF
ABPTK
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACRPL
ADNMO
CITATION
7QL
7T7
8FD
C1K
FR3
P64
ID FETCH-LOGICAL-c559t-b8fa5007422485cf94f1a804d0f4a92add35425676f1330c2b8cbff816abfad13
IEDL.DBID AIKHN
ISSN 0924-8579
IngestDate Fri Oct 25 04:14:35 EDT 2024
Fri Dec 06 05:21:00 EST 2024
Sat Sep 28 08:17:11 EDT 2024
Sun Oct 22 16:09:46 EDT 2023
Fri Feb 23 02:31:07 EST 2024
Tue Oct 15 22:55:12 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Stenotrophomonas maltophilia
EGCG
Pseudomonadales
Human
Biological activity
Antimicrobial agent
Polyphenol
Epigallocatechin gallate
Phenols
Bacteria
Pseudomonadaceae
Clinical isolate
Green tea
Language English
License CC BY 4.0
Copyright (c) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c559t-b8fa5007422485cf94f1a804d0f4a92add35425676f1330c2b8cbff816abfad13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 20472404
PQID 754538519
PQPubID 23462
PageCount 3
ParticipantIDs proquest_miscellaneous_754538519
crossref_primary_10_1016_j_ijantimicag_2010_03_025
pubmed_primary_20472404
pascalfrancis_primary_22980179
elsevier_sciencedirect_doi_10_1016_j_ijantimicag_2010_03_025
elsevier_clinicalkeyesjournals_1_s2_0_S0924857910001597
PublicationCentury 2000
PublicationDate 2010-08-01
PublicationDateYYYYMMDD 2010-08-01
PublicationDate_xml – month: 08
  year: 2010
  text: 2010-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle International journal of antimicrobial agents
PublicationTitleAlternate Int J Antimicrob Agents
PublicationYear 2010
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Andrews (bib11) 2009; 64
Crossman, Gould, Dow, Vernikos, Okazaki, Sebaihia (bib5) 2008; 17
Rogues, Maugein, Allery, Fleureau, Boulestreau, Surcin (bib2) 2001; 49
Kuriyama, Shimazu, Ohmori, Kikuchi, Nakaya, Nishino (bib8) 2006; 296
Javaid, Bonkovsky (bib19) 2006; 45
Verweij, Meis, Christmann, Van der Bor, Melchers, Hilderink (bib4) 1998; 120
Navarro-Martínez, Navarro-Perán, Cabezas-Herrera, Ruiz-Gómez, García-Cánovas, Rodríguez-López (bib17) 2005; 49
Ikigai, Nakae, Hara, Shimamura (bib15) 1993; 1147
Camouse, Domingo, Swain, Conrad, Matsui, Maes (bib20) 2009; 18
Kim, Kawazoe, Han, Matsumara, Tsutsumi, Hyon (bib21) 2008; 16
Toleman, Bennett, Bennett, Jones, Walsh (bib6) 2007; 13
Moriarty, Elborn, Tunney (bib12) 2005; 61
Park, Park, Taguchi, Fukushima, Hyon, Takatori (bib14) 2006; 347
Gradisar, Pristovsek, Plaper, Jerala (bib16) 2007; 50
Bernal, Zloh, Taylor (bib23) 2009; 63
Yoda, Hu, Zhao, Shimamura (bib9) 2004; 10
Unno, Kondo, Itakura, Takeo (bib18) 1996; 60
Zhao, Asano, Hu, Shimamura (bib22) 2003; 55
Weber, Rutala, Blanchet, Jordan, Gergen (bib3) 1999; 27
Osterburg, Gardner, Hyon, Neely, Babcock (bib10) 2009; 15
Nicodemo, Garcia Paez (bib7) 2007; 26
Denton, Kerr (bib1) 1998; 11
Anand, Kaul, Sharma (bib13) 2006; 38
Navarro-Martínez (10.1016/j.ijantimicag.2010.03.025_bib17) 2005; 49
Park (10.1016/j.ijantimicag.2010.03.025_bib14) 2006; 347
Denton (10.1016/j.ijantimicag.2010.03.025_bib1) 1998; 11
Unno (10.1016/j.ijantimicag.2010.03.025_bib18) 1996; 60
Rogues (10.1016/j.ijantimicag.2010.03.025_bib2) 2001; 49
Nicodemo (10.1016/j.ijantimicag.2010.03.025_bib7) 2007; 26
Gradisar (10.1016/j.ijantimicag.2010.03.025_bib16) 2007; 50
Bernal (10.1016/j.ijantimicag.2010.03.025_bib23) 2009; 63
Verweij (10.1016/j.ijantimicag.2010.03.025_bib4) 1998; 120
Crossman (10.1016/j.ijantimicag.2010.03.025_bib5) 2008; 17
Ikigai (10.1016/j.ijantimicag.2010.03.025_bib15) 1993; 1147
Weber (10.1016/j.ijantimicag.2010.03.025_bib3) 1999; 27
Toleman (10.1016/j.ijantimicag.2010.03.025_bib6) 2007; 13
Moriarty (10.1016/j.ijantimicag.2010.03.025_bib12) 2005; 61
Camouse (10.1016/j.ijantimicag.2010.03.025_bib20) 2009; 18
Yoda (10.1016/j.ijantimicag.2010.03.025_bib9) 2004; 10
Kim (10.1016/j.ijantimicag.2010.03.025_bib21) 2008; 16
Andrews (10.1016/j.ijantimicag.2010.03.025_bib11) 2009; 64
Anand (10.1016/j.ijantimicag.2010.03.025_bib13) 2006; 38
Osterburg (10.1016/j.ijantimicag.2010.03.025_bib10) 2009; 15
Javaid (10.1016/j.ijantimicag.2010.03.025_bib19) 2006; 45
Zhao (10.1016/j.ijantimicag.2010.03.025_bib22) 2003; 55
Kuriyama (10.1016/j.ijantimicag.2010.03.025_bib8) 2006; 296
References_xml – volume: 10
  start-page: 55
  year: 2004
  end-page: 58
  ident: bib9
  article-title: Different susceptibilities of
  publication-title: J Infect Chemother
  contributor:
    fullname: Shimamura
– volume: 15
  start-page: 341
  year: 2009
  end-page: 346
  ident: bib10
  article-title: Highly antibiotic-resistant
  publication-title: Clin Microbiol Infect
  contributor:
    fullname: Babcock
– volume: 49
  start-page: 2914
  year: 2005
  end-page: 2920
  ident: bib17
  article-title: Antifolate activity of epigallocatechin gallate against
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Rodríguez-López
– volume: 120
  start-page: 251
  year: 1998
  end-page: 256
  ident: bib4
  article-title: Nosocomial outbreak of colonization and infection with
  publication-title: Epidemiol Infect
  contributor:
    fullname: Hilderink
– volume: 63
  start-page: 1156
  year: 2009
  end-page: 1162
  ident: bib23
  article-title: Disruption of
  publication-title: J Antimicrob Chemother
  contributor:
    fullname: Taylor
– volume: 11
  start-page: 57
  year: 1998
  end-page: 80
  ident: bib1
  article-title: Microbiological and clinical aspects of infection associated with
  publication-title: Clin Microbiol Rev
  contributor:
    fullname: Kerr
– volume: 49
  start-page: 289
  year: 2001
  end-page: 292
  ident: bib2
  article-title: Electronic ventilator temperature sensors as a potential source of respiratory tract colonization with
  publication-title: J Hosp Infect
  contributor:
    fullname: Surcin
– volume: 38
  start-page: 600
  year: 2006
  end-page: 609
  ident: bib13
  article-title: Green tea polyphenol inhibits
  publication-title: Int J Biochem Cell Biol
  contributor:
    fullname: Sharma
– volume: 1147
  start-page: 132
  year: 1993
  end-page: 136
  ident: bib15
  article-title: Bactericidal catechins damage the lipid bilayer
  publication-title: Biochim Biophys Acta
  contributor:
    fullname: Shimamura
– volume: 45
  start-page: 334
  year: 2006
  end-page: 335
  ident: bib19
  article-title: Hepatotoxicity due to extracts of Chinese green tea (
  publication-title: J Hepatol
  contributor:
    fullname: Bonkovsky
– volume: 60
  start-page: 2066
  year: 1996
  end-page: 2068
  ident: bib18
  article-title: Analysis of (−)-epigallocatechin in human serum obtained after ingesting green tea
  publication-title: Biosci Biotechnol Biochem
  contributor:
    fullname: Takeo
– volume: 13
  start-page: 559
  year: 2007
  end-page: 565
  ident: bib6
  article-title: Global emergence of trimethoprim/sulfamethoxazole resistance in
  publication-title: Emerg Infect Dis
  contributor:
    fullname: Walsh
– volume: 64
  start-page: 454
  year: 2009
  end-page: 489
  ident: bib11
  article-title: BSAC standardized disc susceptibility testing method (version 8)
  publication-title: J Antimicrob Chemother
  contributor:
    fullname: Andrews
– volume: 26
  start-page: 229
  year: 2007
  end-page: 237
  ident: bib7
  article-title: Antimicrobial therapy for
  publication-title: Eur J Clin Microbiol Infect Dis
  contributor:
    fullname: Garcia Paez
– volume: 16
  start-page: 714
  year: 2008
  end-page: 720
  ident: bib21
  article-title: Enhanced wound healing by an epigallocatechin-incorporated collagen sponge in diabetic mice
  publication-title: Wound Repair Regen
  contributor:
    fullname: Hyon
– volume: 50
  start-page: 264
  year: 2007
  end-page: 271
  ident: bib16
  article-title: Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site
  publication-title: J Med Chem
  contributor:
    fullname: Jerala
– volume: 347
  start-page: 401
  year: 2006
  end-page: 405
  ident: bib14
  article-title: Antifungal susceptibility of epigallocatechin 3-
  publication-title: Biochem Biophys Res Commun
  contributor:
    fullname: Takatori
– volume: 55
  start-page: 735
  year: 2003
  end-page: 740
  ident: bib22
  article-title: Restoration of antibacterial activity of β-lactams by epigallocatechin gallate against β-lactamase-producing species depending on location of β-lactamase
  publication-title: J Pharm Pharmacol
  contributor:
    fullname: Shimamura
– volume: 61
  start-page: 171
  year: 2005
  end-page: 179
  ident: bib12
  article-title: Development of a rapid colorimetric time–kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against
  publication-title: J Microbiol Methods
  contributor:
    fullname: Tunney
– volume: 27
  start-page: 59
  year: 1999
  end-page: 63
  ident: bib3
  article-title: Faucet aerators: a source of patient colonization with
  publication-title: Am J Infect Control
  contributor:
    fullname: Gergen
– volume: 17
  start-page: R74
  year: 2008
  ident: bib5
  article-title: The complete genome, comparative and functional analysis of
  publication-title: Genome Biol
  contributor:
    fullname: Sebaihia
– volume: 296
  start-page: 1255
  year: 2006
  end-page: 1265
  ident: bib8
  article-title: Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan: the Ohsaki study
  publication-title: JAMA
  contributor:
    fullname: Nishino
– volume: 18
  start-page: 522
  year: 2009
  end-page: 526
  ident: bib20
  article-title: Topical application of green and white tea extract provides protection from solar-simulated ultraviolet light in human skin
  publication-title: Exp Dermatol
  contributor:
    fullname: Maes
– volume: 10
  start-page: 55
  year: 2004
  ident: 10.1016/j.ijantimicag.2010.03.025_bib9
  article-title: Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate
  publication-title: J Infect Chemother
  doi: 10.1007/s10156-003-0284-0
  contributor:
    fullname: Yoda
– volume: 26
  start-page: 229
  year: 2007
  ident: 10.1016/j.ijantimicag.2010.03.025_bib7
  article-title: Antimicrobial therapy for Stenotrophomonas maltophilia infections
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-007-0279-3
  contributor:
    fullname: Nicodemo
– volume: 17
  start-page: R74
  year: 2008
  ident: 10.1016/j.ijantimicag.2010.03.025_bib5
  article-title: The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants
  publication-title: Genome Biol
  doi: 10.1186/gb-2008-9-4-r74
  contributor:
    fullname: Crossman
– volume: 60
  start-page: 2066
  year: 1996
  ident: 10.1016/j.ijantimicag.2010.03.025_bib18
  article-title: Analysis of (−)-epigallocatechin in human serum obtained after ingesting green tea
  publication-title: Biosci Biotechnol Biochem
  doi: 10.1271/bbb.60.2066
  contributor:
    fullname: Unno
– volume: 16
  start-page: 714
  year: 2008
  ident: 10.1016/j.ijantimicag.2010.03.025_bib21
  article-title: Enhanced wound healing by an epigallocatechin-incorporated collagen sponge in diabetic mice
  publication-title: Wound Repair Regen
  doi: 10.1111/j.1524-475X.2008.00422.x
  contributor:
    fullname: Kim
– volume: 347
  start-page: 401
  year: 2006
  ident: 10.1016/j.ijantimicag.2010.03.025_bib14
  article-title: Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.06.037
  contributor:
    fullname: Park
– volume: 45
  start-page: 334
  year: 2006
  ident: 10.1016/j.ijantimicag.2010.03.025_bib19
  article-title: Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2006.05.005
  contributor:
    fullname: Javaid
– volume: 49
  start-page: 289
  year: 2001
  ident: 10.1016/j.ijantimicag.2010.03.025_bib2
  article-title: Electronic ventilator temperature sensors as a potential source of respiratory tract colonization with Stenotrophomonas maltophilia
  publication-title: J Hosp Infect
  doi: 10.1053/jhin.2001.1099
  contributor:
    fullname: Rogues
– volume: 11
  start-page: 57
  year: 1998
  ident: 10.1016/j.ijantimicag.2010.03.025_bib1
  article-title: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.11.1.57
  contributor:
    fullname: Denton
– volume: 120
  start-page: 251
  year: 1998
  ident: 10.1016/j.ijantimicag.2010.03.025_bib4
  article-title: Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water
  publication-title: Epidemiol Infect
  doi: 10.1017/S0950268898008735
  contributor:
    fullname: Verweij
– volume: 63
  start-page: 1156
  year: 2009
  ident: 10.1016/j.ijantimicag.2010.03.025_bib23
  article-title: Disruption of d-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the β-lactam resistance modifier (−)-epicatechin gallate
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkp094
  contributor:
    fullname: Bernal
– volume: 296
  start-page: 1255
  year: 2006
  ident: 10.1016/j.ijantimicag.2010.03.025_bib8
  article-title: Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan: the Ohsaki study
  publication-title: JAMA
  doi: 10.1001/jama.296.10.1255
  contributor:
    fullname: Kuriyama
– volume: 64
  start-page: 454
  year: 2009
  ident: 10.1016/j.ijantimicag.2010.03.025_bib11
  article-title: BSAC standardized disc susceptibility testing method (version 8)
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkp244
  contributor:
    fullname: Andrews
– volume: 27
  start-page: 59
  year: 1999
  ident: 10.1016/j.ijantimicag.2010.03.025_bib3
  article-title: Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia
  publication-title: Am J Infect Control
  doi: 10.1016/S0196-6553(99)70077-5
  contributor:
    fullname: Weber
– volume: 50
  start-page: 264
  year: 2007
  ident: 10.1016/j.ijantimicag.2010.03.025_bib16
  article-title: Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site
  publication-title: J Med Chem
  doi: 10.1021/jm060817o
  contributor:
    fullname: Gradisar
– volume: 18
  start-page: 522
  year: 2009
  ident: 10.1016/j.ijantimicag.2010.03.025_bib20
  article-title: Topical application of green and white tea extract provides protection from solar-simulated ultraviolet light in human skin
  publication-title: Exp Dermatol
  doi: 10.1111/j.1600-0625.2008.00818.x
  contributor:
    fullname: Camouse
– volume: 55
  start-page: 735
  year: 2003
  ident: 10.1016/j.ijantimicag.2010.03.025_bib22
  article-title: Restoration of antibacterial activity of β-lactams by epigallocatechin gallate against β-lactamase-producing species depending on location of β-lactamase
  publication-title: J Pharm Pharmacol
  doi: 10.1211/002235703765951320
  contributor:
    fullname: Zhao
– volume: 38
  start-page: 600
  year: 2006
  ident: 10.1016/j.ijantimicag.2010.03.025_bib13
  article-title: Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2005.10.021
  contributor:
    fullname: Anand
– volume: 49
  start-page: 2914
  year: 2005
  ident: 10.1016/j.ijantimicag.2010.03.025_bib17
  article-title: Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.49.7.2914-2920.2005
  contributor:
    fullname: Navarro-Martínez
– volume: 13
  start-page: 559
  year: 2007
  ident: 10.1016/j.ijantimicag.2010.03.025_bib6
  article-title: Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1304.061378
  contributor:
    fullname: Toleman
– volume: 61
  start-page: 171
  year: 2005
  ident: 10.1016/j.ijantimicag.2010.03.025_bib12
  article-title: Development of a rapid colorimetric time–kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa
  publication-title: J Microbiol Methods
  doi: 10.1016/j.mimet.2004.11.010
  contributor:
    fullname: Moriarty
– volume: 1147
  start-page: 132
  year: 1993
  ident: 10.1016/j.ijantimicag.2010.03.025_bib15
  article-title: Bactericidal catechins damage the lipid bilayer
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2736(93)90323-R
  contributor:
    fullname: Ikigai
– volume: 15
  start-page: 341
  year: 2009
  ident: 10.1016/j.ijantimicag.2010.03.025_bib10
  article-title: Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG)
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2009.02710.x
  contributor:
    fullname: Osterburg
SSID ssj0015345
Score 2.3607817
Snippet Abstract Stenotrophomonas maltophilia is increasingly recognised as an important nosocomial pathogen. Treatment options are limited due to intrinsic resistance...
Stenotrophomonas maltophilia is increasingly recognised as an important nosocomial pathogen. Treatment options are limited due to intrinsic resistance to many...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 129
SubjectTerms Agar
Anti-Bacterial Agents - pharmacology
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Camellia sinensis
Catechin - analogs & derivatives
Catechin - pharmacology
EGCG
Gram-Negative Bacterial Infections - microbiology
Humans
Infectious Disease
Medical sciences
Microbial Sensitivity Tests
Pharmacology. Drug treatments
Stenotrophomonas maltophilia
Stenotrophomonas maltophilia - drug effects
Stenotrophomonas maltophilia - isolation & purification
Title Antimicrobial activity of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0924857910001597
https://dx.doi.org/10.1016/j.ijantimicag.2010.03.025
https://www.ncbi.nlm.nih.gov/pubmed/20472404
https://search.proquest.com/docview/754538519
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9RAFD70giKIaLW6XpYRpLTQ6U6SySYBX5al7Xori22hb8MkmVlT1k1otg_74rPP4i_0l3hOLrsWFQQfJ2SSSc5lvuF85xyAV76QOvaM4b72DZfSj3icODjEQ48RkU39iLKRP5z0R-fy7YV_sQbDNheGaJWN7699euWtmyu95m_2iizrnYqIynEFkVPlA0fBOmzidkSx2s3Bm3ejk2UwwfeqXsV0P6cJt-HliuaVXeIXZJSaP2mIXt6BoMbZf96m7ha6xJ9n664Xf4el1fZ0dB_uNbiSDeqlP4A1M9uCW3WnycUW7IzrEtWLfXa2yrgq99kOG6-KVy8ewvdBvU4qz4TPo7QH6i7BcssQKrIJ0XQYKgYr8umC-GH5lO3--Pptj5siq6L4RLEigib3OI1xxHYPj4fHe0xPdIZolLXZmCxDxSesS08_RfCez6_y4lOOlqFL9llPqehBNs30Izg_OjwbjnjTuYEneEKZ8zi01GkBj90kosRG0jo6FDIVVurIRZ_q-egs-kHf4hlZJG4cJrG1odPXsdWp423DxiyfmSfApEnDIEaUqAOEbj6FRYVJHG1SN3ZkbDrgtoJSRV2gQ7XMtUv1i3QVSVcJT6F0OxC0IlXtN6PPNGVjwKVyVOkqoX5Tsg68Xs68oacKt6B_eXH3hgItl-y6UUjOsQOs1SiFhk7RGz0z-XWpAsS6HuJjvOVxrWmryVTyUwr59P8W9wzu1NwIojc-h4351bV5gZBrHndh_eCL00XDGn58P-42BvYTSXkxAQ
link.rule.ids 314,780,784,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fa9swED-6lq2DMbau27I_nQajtFAvsi3HNuwlhLbp2oZCU-ibkGwpdcliU6cP-QZ7HvuE-yS7i-1kZRsM9igjyZLudPoJ_e4O4EPAhdK-MU6gAuMIEcSOTlws4qXH8NimQUzeyKeDTv9CfL4MLleg1_jCEK2ytv2VTZ9b6_pLu17NdpFl7XMeUziuMHbn_sBxeA_WEA2EqNpr3aPj_mDxmBD481zFVN-hBg_g_ZLmlV3jDDJyzR_VRC__I6fE2X8-ph4VqsTFs1XWi7_D0vnxdPAEHte4knWroT-FFTPZgPtVpsnZBmyfVSGqZ3tsuPS4KvfYNjtbBq-ePYPv3WqcFJ4J-yO3B8ouwXLLECqyEdF0GCoGK_LxjPhh-Zjt_Pj6bdcxRTZ_xSeKFRE0Hd-hMpbYzv5h73CXqZHKEI2yxhuTZaj4hHWp93ME7_n0Ji-uctwZqmRf1JiCHmTjTG3CxcH-sNd36swNToI3lKmjI0uZFvDaTSJKbCysqyIuUm6Fij20qX6AxqITdizekXni6SjR1kZuR2mrUtd_DquTfGJeAhMmjUKNKFGFCN0CehblJnGVST3tCm1a4DWCkkUVoEM2zLVr-Yt0JUlXcl-idFsQNiKVzZzRZpqy3sCldGXpSS5_U7IWfFq0vKOnEo-gf_nx1h0FWgzZ8-KIjGMLWKNREjc6vd6oiclvSxki1vURH2OVF5WmLRtTyE_Bxav_G9w7WO8PT0_kydHg-DU8rHgSRHV8A6vTm1vzFuHXVG_V2-snODIxaQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antimicrobial+activity+of+the+green+tea+polyphenol+%28%E2%88%92%29-epigallocatechin-3-gallate+%28EGCG%29+against+clinical+isolates+of+Stenotrophomonas+maltophilia&rft.jtitle=International+journal+of+antimicrobial+agents&rft.au=Gordon%2C+Nicola+C.&rft.au=Wareham%2C+David+W.&rft.date=2010-08-01&rft.pub=Elsevier+B.V&rft.issn=0924-8579&rft.eissn=1872-7913&rft.volume=36&rft.issue=2&rft.spage=129&rft.epage=131&rft_id=info:doi/10.1016%2Fj.ijantimicag.2010.03.025&rft.externalDocID=S0924857910001597
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09248579%2FS0924857910X00061%2Fcov150h.gif